Janus Kinase inhibitors #JAKi are approved for 14 conditions in #rheumatology, gastroenterology and #dermatology

New #scoping #review reveals their expanding off-licence use in 35 immune-mediated inflammatory diseases

More high-quality research is needed

#autoimmunity https://doi.org/10.1016/j.autrev.2024.103736